PharmaCyte Biotech Inc (PMCB)

[PINKribbon]

This will help you find the information.

And again, it is CLEARLY there, READILY AVAILABLE for all to see.

USPTO: When a continuation or divisional application (other than a CPA) is filed, applicant should file a clean copy of the specification, including any required amendments. See 37 CFR 1.215(a). A copy of a previously-executed oath or declaration may still be filed with the clean copy of the specification. See 37 CFR 1.63(d) and Changes to Patent Practice and Procedure ; Final Rule, 62 Fed. Reg. 53131, 53148 (October 10, 1997), 1203 Off. Gaz. Pat. Office 63, 77 (October 21, 1997). If preliminary amendments are filed, the preliminary amendments (new claims, etc.) will not be reflected in the patent application publication, unless they are submitted as part of a submission through the Electronic Filing System (EFS). See 37 CFR 1.215(c). For a CPA, the application that is published is the application as originally filed, i.e., the prior application, and a substitute specification will only be used for creating the patent application publication if it is submitted through EFS.


Patience

Go Team PharmaCyte!!!